| 1. |
- Namli, Elena, et al.
(författare)
-
Introduction
- 2014
-
Ingår i: Jewish Thought, Utopia and Revolution. - 9789042038332 ; , s. 1-7
-
Bokkapitel (refereegranskat)
|
|
| 2. |
|
|
| 3. |
- Svenungsson, Jayne, et al.
(författare)
-
Inledning
- 2007
-
Ingår i: Systematisk teologi : En introduktion - En introduktion. - 9789152631492 ; , s. 9-20
-
Bokkapitel (övrigt vetenskapligt/konstnärligt)
|
|
| 4. |
- Svenungsson, Jayne, et al.
(författare)
-
Introduction : Heidegger and Theology after the Black Notebooks
- 2017
-
Ingår i: Heidegger’s Black Notebooks and the Future of Theology. - Cham : Springer International Publishing. - 9783319649269 ; , s. 1-22
-
Bokkapitel (refereegranskat)abstract
- This introductory chapter gives an overview of the intricate relation between Heidegger and theology. Firstly, it discusses Heidegger’s indebtedness to theology by revisiting the debate that was initiated by the publication of his early Freiburg lectures in the 1990s. Second, it sketches in broad strokes the reception history of Heidegger’s works within twentieth century theology. In the third and final part, the implication of the new facts revealed by the Black Notebooks are discussed. By revisiting Hans Jonas’s lecture ‘Heidegger and Theology’, delivered at Drew University in 1964, the author indicates how Jonas already in the 1960s revealed the potential shortcomings of a theology that takes its basics tenets from Heidegger’s philosophy.
|
|
| 5. |
- Svenungsson, Jayne, et al.
(författare)
-
Introduction : The Ethos of History
- 2018
-
Ingår i: The Ethos of History : Time and Responsibility - Time and Responsibility. - 9781785338847 - 9781785338854 ; 34, s. 1-13
-
Bokkapitel (refereegranskat)
|
|
| 6. |
|
|
| 7. |
- Carlsson, Peter
(författare)
-
Teologi som kritik : Graham Ward och den postsekulära hermeneutiken
- 2017
-
Doktorsavhandling (övrigt vetenskapligt/konstnärligt)abstract
- The British theologian Graham Ward has since the 1990 ́s been one of the most prominent voices in the theological discussions of the Anglo-American cultural sphere. As one of the key figures in the academic field that has been known as “post secularism”, “the resurgence of religion” or “the new visibility of religion” Ward has developed an independent theological position that most properly could be described as a Christian cultural critique. Deeply informed by continental critical theory Ward has attempted to analyze and categorize contemporary culture in terms of Christian theology. The thesis argued for in the present dis- sertation is that there is a unique resource in Christian theology, as at least partly captured in Wards project, for imagining a vision of a better future. By drawing on a negative strand of the Christian tradition, theology can find a capacity to articulate visions of a better world that, which is the crucial warning of critical theory, does not give in to utopian dreams and wishful thinking.The dissertation aims to present and analyze Wards project in order to lay the foundation for a theological critique of culture – an activity that draws on the material aspects of a religious tradition. The first part of the dissertation (chapter 2–5) consists of a presentation and an immanent critical analysis of Graham Wards project. The analysis is pursued under four distinct categories: metaphysics, anthropology, politics and apologetics. In these chapters, Wards theology is presented and analyzed through a contextualization within the Christian tradition and critical theory. In chapter 6, Wards theology is brought into a critical dialogue with three other theologians who work in the intersection point between critical theory and Christian theology – Mark C. Taylor, John D. Caputo and Jean Luc Marion – but have come to different conclusions regarding how this relation is to be understood. The dissertation argues that a theology that makes visible the particular standpoint and stresses the material resources of religion stands the best chance of becoming at critical and transformative force in contemporary culture.The last chapter is organized around six conditions that, working as an ex- tension of Wards project, are necessary for a theological critique of culture; the particular proviso, affirmative critique, ontological critique, theology and practice, methodological pragmatism and critique of faith. This works toward sketching a post-secular hermeneutics – an interdisciplinary field of research that take the theological traditions in full consideration when interpreting the configurations of thought and actions that we refer to as culture.
|
|
| 8. |
- Chavatza, K, et al.
(författare)
-
EULAR RECOMMENDATION-BASED QUALITY INDICATORS (QIS) FOR SYSTEMIC LUPUS ERYTHEMATOSUS (SLE): ELABORATION, FINAL SET, PERFORMANCE AND INITIAL VALIDATION
- 2021
-
Ingår i: ANNALS OF THE RHEUMATIC DISEASES. - : BMJ. - 0003-4967 .- 1468-2060. ; 80, s. 635-636
-
Konferensbidrag (övrigt vetenskapligt/konstnärligt)abstract
- Targets of therapy and quality of care are receiving increased attention in systemic lupus erythematosus (SLE).Objectives:To develop Quality Indicators (QIs) for the care of SLE patients based on the EULAR recommendations, and assess their performance.Methods:Using the published EULAR recommendations for SLE, we developed 44 candidate QIs. These were independently rated for validity and feasibility by 12 experts, analysed by a modified RAND/UCLA model and further scrutinized based on the scorings and expert opinion. (Fig.1) Adherence to the final set of QIs was tested in a cohort of 220 SLE patients combined with an assessment on its impact on disease outcomes such as flares, hospitalizations and organ damage.Results:The panel rated 18 QIs as valid and feasible. These involve diagnosis; disease and damage assessment; monitoring for lupus nephritis and drug toxicity; therapy and targets of therapy; fertility and pregnancy; and adjunct therapy (preventive measures for osteoporosis, vaccination, cardiovascular disease). On average, SLE patients received 54% (95%CI 52–56%) of the indicated care with adherence ranging from 41% for QIs related to monitoring to 88% for treatment-related QIs. Regarding targets of therapy, sustained remission or low disease activity were achieved in 27%, while 94% of patients received low-dose glucocorticoids, and 92% the recommended hydroxychloroquine dose. Dependent upon individual QI tested, adherence for lupus nephritis-related QIs was 88% for receiving appropriate adjunct therapy (ACE inhibitors) to 100% for being treated with the indicated immunosuppressive treatment. In contrast, adherence to QIs related to preventive measures and other adjunct therapies was moderate to low. Notably, patients who were eligible for cardiovascular risk modification, vaccination, and osteoporosis management received lower quality of care (40.5%, 47.7% and 45.5% respectively) while 91.4% had sunscreen protection. In reference to laboratory work-up and monitoring, complete laboratory work-up at diagnosis was performed in 48%, while disease activity and damage, were fully assessed only in 14.1% (in three consecutive visits) and 28.6% (annually) respectively, Similarly, reproductive health and pregnancy counselling adherence rates were modest estimated at 50% and 62% respectively. Higher adherence to the indicated care during follow-up (monitoring QIs) was associated with reduced risk for adverse outcomes during the last year of observation (OR 0.97, 95%CI 0.96-0.99). Patients who achieved sustained remission or LLDAS, exhibited fewer flares (OR=0.15, p-value<0.001) and damage accrual (OR=0.35, p-value<0.001). Of interest, patients who received low-dose of GCs or were appropriately vaccinated, had a lower risk of experiencing a flare (OR=0.23 and 0.46 respectively).Conclusion:A set of 18 QIs based on the EULAR recommendations for SLE was developed to be used towards improving care in SLE. Initial real-life data suggest variable degree of adherence with higher adherence resulting in reduced adverse outcomes.References:[1]Fanouriakis, et al., 2019 Update of the EULAR recommendations for the management of systemic lupus erythematosus. In Annals of the Rheumatic Diseases (Vol. 78, Issue 6, pp. 736–745). BMJ Publishing Group. https://doi.org/10.1136/annrheumdis-2019-215089.[2]Nikolopoulos, D., et al., Evolving phenotype of systemic lupus erythematosus in Caucasians: low incidence of lupus nephritis, high burden of neuropsychiatric disease and increased rates of late-onset lupus in the ‘Attikon’ cohort. Lupus, 29(5), 514–522. https://doi.org/10.1177/0961203320908932.Acknowledgements:This project has received funding from the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation programme (grant agreement No 742390)Disclosure of Interests:None declared
|
|
| 9. |
- Chavatza, K, et al.
(författare)
-
Quality indicators for systemic lupus erythematosus based on the 2019 EULAR recommendations: development and initial validation in a cohort of 220 patients
- 2021
-
Ingår i: Annals of the rheumatic diseases. - : BMJ. - 1468-2060 .- 0003-4967. ; 80:9, s. 1175-1182
-
Tidskriftsartikel (refereegranskat)abstract
- Quality of care is receiving increased attention in systemic lupus erythematosus (SLE). We developed quality indicators (QIs) for SLE based on the 2019 update of European League Against Rheumatism recommendations.MethodsA total of 44 candidate QIs corresponding to diagnosis, monitoring and treatment, were independently rated for validity and feasibility by 12 experts and analysed by a modified Research and Development Corporation/University of California Los Angeles model. Adherence to the final set of QIs and correlation with disease outcomes (flares, hospitalisations and organ damage) was tested in a cohort of 220 SLE patients with a median monitoring of 2 years (IQR 2–4).ResultsThe panel selected a total of 18 QIs as valid and feasible. On average, SLE patients received 54% (95% CI 52.3% to 56.2%) of recommended care, with adherence ranging from 44.7% (95% CI 40.8% to 48.6%) for diagnosis-related QIs to 84.3% (95% CI 80.6% to 87.5%) for treatment-related QIs. Sustained remission or low disease activity were achieved in 26.8% (95% CI 21.1% to 33.2%). Tapering of prednisone dose to less than 7.5 mg/day was achieved in 93.6% (95% CI 88.2% to 97.0%) while 73.5% (95% CI 66.6% to 79.6%) received the recommended hydroxychloroquine dose. Higher adherence to monitoring-related QIs was associated with reduced risk for a composite adverse outcome (flare, hospitalisation or damage accrual) during the last year of observation (OR 0.97 per 1% adherence rate, 95% CI 0.96 to 0.99).ConclusionWe developed QIs for assessing and improving the care of SLE patients. Initial real-life data suggest face validity, but a variable degree of adherence and a need for further improvement.
|
|
| 10. |
- Fanouriakis, A, et al.
(författare)
-
2019 update of the EULAR recommendations for the management of systemic lupus erythematosus
- 2019
-
Ingår i: Annals of the rheumatic diseases. - : BMJ. - 1468-2060 .- 0003-4967. ; 78:6, s. 736-745
-
Tidskriftsartikel (refereegranskat)abstract
- Our objective was to update the EULAR recommendations for the management of systemic lupus erythematosus (SLE), based on emerging new evidence. We performed a systematic literature review (01/2007–12/2017), followed by modified Delphi method, to form questions, elicit expert opinions and reach consensus. Treatment in SLE aims at remission or low disease activity and prevention of flares. Hydroxychloroquine is recommended in all patients with lupus, at a dose not exceeding 5 mg/kg real body weight. During chronic maintenance treatment, glucocorticoids (GC) should be minimised to less than 7.5 mg/day (prednisone equivalent) and, when possible, withdrawn. Appropriate initiation of immunomodulatory agents (methotrexate, azathioprine, mycophenolate) can expedite the tapering/discontinuation of GC. In persistently active or flaring extrarenal disease, add-on belimumab should be considered; rituximab (RTX) may be considered in organ-threatening, refractory disease. Updated specific recommendations are also provided for cutaneous, neuropsychiatric, haematological and renal disease. Patients with SLE should be assessed for their antiphospholipid antibody status, infectious and cardiovascular diseases risk profile and preventative strategies be tailored accordingly. The updated recommendations provide physicians and patients with updated consensus guidance on the management of SLE, combining evidence-base and expert-opinion.
|
|
